Welcome Guest
Sign In
Register
Products
Popular Categories
Antibody Search
ELISA Kit Search
Biomolecules
Flow Cytometers
Thermal Cyclers
Microscopes
Transfection Reagents
Featured Products
New Products
Articles
Resources
eBooks
Bench Tips
Tech Insights
Editorial Articles
News
Product Reviews
Future Lab
Multimedia
Biocompare Webinars
Immunotherapy
Reproducibility
Transformative Technologies
Podcasts
Tech Talks
Bench Tip Videos
All Videos and Webinars
Life Science Webinars
Write a Review
Antibodies
Kits/Reagents
Equipment
Services
Resources
Promotions
Events
AACR SPOTLIGHT
Register
Sign In
Biocompare
Products
Antibodies
Antibodies
Anti-HEF1/NEDD-9 antibody [2G9]
Anti-HEF1/NEDD-9 antibody [2G9] from Abcam
Be the first to write a review!
Citations:
(28)
Supplier Page
Supplier Page from
Abcam for
Anti-HEF1/NEDD-9 antibody [2G9]
Product Specs
Company Info
Citations
Reviews
Product Specs
Item
Anti-HEF1/NEDD-9 antibody [2G9]
Company
Abcam
Price
Pricing Info
Supplier Page
View Company Product Page
Catalog Number
ab18056
Antibody Type
Primary
Isotype
IgG1
Clonality
Monoclonal
Clone
2G9
Host
Mouse, Nude mouse
Applications
Flow Cytometry, Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections), Western blot
Quantity
100 UL
Conjugate/Tag
Unconjugated
Concentration
1 mg/ml
Gene Name
NEDD9
Reactivity
Human
Target
HEF1 / NEDD-9
Add to Compare List
Abcam
Discovery Drive
Cambridge Biomedical Campus
Cambridge
CB2 0AX
United Kingdom
Phone
: +44 (0) 1223 696000 (option 1)
+44 (0) 1223 696000 (option 2)
+44 (0) 1223 771600
Company Profile
Website:
http://www.abcam.com
Citations (28)
(1)
Histone deacetylase inhibitors promote breast cancer metastasis by elevating NEDD9 expression
Signal transduction and targeted therapy
January 6, 2023
Hu Z, Wei F, Su Y, Wang Y, Shen Y, Fang Y, Ding J, Chen Y.
dehydrated, paraffin-embedded, and deparaffinized before being incubated with
NEDD9
antibody (
1:200
, #
ab18056
,
Abcam
),
Anti-Histone H3 (acetyl K9
) (
1:200
, #
ab10812
, Abcam) and Phospho-
FAK
(Tyr397) (
1:200
, # 44-624
(2)
miR-107 is involved in the regulation of NEDD9-mediated invasion and metastasis in breast cancer
BMC Cancer
December 1, 2022
Jiamin Zhou, Xianglin Sun, Xinyu Zhang, Huan Yang, Zhenglin Jiang, Qianqian Luo, Yifei Liu, Guohua Wang
acetate
membrane
. After blocking with 5% skim milk, the
membrane
was incubated with NEDD9 (
1:1000
,
ab18056
,
Abcam
, USA) and β-actin (
1:10000
,
A5316
,
Sigma
, USA) antibodies at 4 °C overnight. The
membrane
was
(3)
NEDD9 Restrains dsDNA Damage Response during Non-Small Cell Lung Cancer (NSCLC) Progression
Cancers (Basel)
May 20, 2022
Mariya Tikhomirova, Iuliia Topchu, Aleksandra Mazitova, Vitaly Barmin, Ekaterina Ratner, Alexey Sabirov, Zinaida Abramova, Alexander Y. Deneka
(Ser216) (#
9528
), p-H2AX (Ser139) (#3257000) (
1:1000
;
Cell Signaling Technology
, Danvers, MA, USA); NEDD9 (
ab18056
,
1:1000
), beta-Actin (
ab49900
,
1:100,000
) (
Abcam
; Cambridge, MA, USA),
Vinculin
(
700062
) (
1:1000
,
Invitrogen
,
(4)
Susceptibility-Associated Genetic Variation in
NEDD9
Contributes to Prostate Cancer Initiation and Progression
Cancer Research
July 15, 2021
Dong Han et al.
protease
inhibitor
cocktail (Thermo Fisher Scientific) and anti-
ERG
(
ab110639
, Abcam), anti-NEDD9 (
ab18056
,
Abcam
), anti-
NANOG
(
3580
,
Cell Signaling
), anti-p-Akt S473 (
4060
,
Cell Signaling
), anti-
Akt
(
9272
,
(5)
Melatonin Inhibits the Progression of Oral Squamous Cell Carcinoma via Inducing miR-25-5p Expression by Directly Targeting NEDD9
Frontiers in Oncology
December 2, 2020
Yanling Wang, Bo Tao, Jiaying Li, Xiaoqun Mao, Wei He, Qinbiao Chen
120 min. Subsequently,
immunoblotting
was performed with specific antibodies against NEDD9 (
1:1000
,
ab18056
,
Abcam
, Cambridge, UK) and b-actin (
1:2000
, b-actin, Abcam, Cambridge, UK). b-actin was used as an internal
(6)
ZMYND10, an epigenetically regulated tumor suppressor, exerts tumor-suppressive functions via miR145-5p/NEDD9 axis in breast cancer
Clinical epigenetics
December 4, 2019
Wang Y, Dan L, Li Q, Li L, Zhong L, Shao B, Yu F, He S, Tian S, He J,
et al
.
blocking buffer for 1 h.
After treatment
, the slides were incubated with anti-HEF1 (NEDD9,
1:150
; #
ab18056
;
Abcam
, USA) at 4 °C. After 20 h, cells were incubated with Alexa Fluor 555-conjugated
goat
anti-
mouse
(7)
Vimentin and Non-Muscle Myosin IIA are Members of the Neural Precursor Cell Expressed Developmentally Down-Regulated 9 (NEDD9) Interactome in Head and Neck Squamous Cell Carcinoma Cells
Translational oncology
January 1, 2019
Semelakova M, Grauzam S, Betadthunga P, Tiedeken J, Coaxum S, Neskey DM, Rosenzweig SA.
subjected to
immunoprecipitation
followed
by Western blot
analysis. Primary antibodies used were: NEDD9 (
ab18056
,
Abcam
), Vimentin (RV202:
sc-32322
mouse
monoclonal antibody,
Santa Cruz
),
Vimentin (D21H3, XP Rabbit mAb
(8)
NEDD9 promotes oncogenic signaling, a stem/mesenchymal gene signature, and aggressive ovarian cancer growth in mice
Oncogene
August 1, 2018
Gabbasov R, Xiao F, Howe CG, Bickel LE, O'Brien SW, Benrubi D, Do TV, Zhou Y, Nicolas E, Cai KQ,
et al
.
pSTAT3Y705 (cat#
9145S
), pan-keratin (cat#
4545
) (
Cell Signaling Technology
; Danvers, MA, USA), NEDD9 (cat#
ab18056
) (
Abcam
; Cambridge, MA, USA), SV40-TAg (cat#
sc-147
), β-actin (cat#
sc-8432
), E-cadherin (cat#
sc-7870
),
(9)
Zoledronic Acid Suppresses Epithelial-to-Mesenchymal Transition and Invasion via Degradation of Ubiquitinated NEDD9 in PC-3 Prostate Cancer Cells
Journal of Cancer Science & Therapy
January 1, 2018
Tomoaki Tanaka, Kazuya Morimoto, Tatsuya Nakatani
the final concentration was 0.5 μM for all the experiments. Antibodies
Mouse
monoclonal anti-NEDD9(
ab18056
), anti-β-actin(
ab8226
), and rabbit polyclonal
anti-Snail+Slug
(
ab63371
) antibodies were obtained from
(10)
Progesterone and calcitriol reduce invasive potential of endometrial cancer cells by targeting ARF6, NEDD9 and MT1-MMP
Oncotarget
December 26, 2017
Waheed S, Dorjbal B, Hamilton CA, Maxwell GL, Rodriguez GC, Syed V.
(11)
Asymmetric localization of DLC1 defines avian trunk neural crest polarity for directional delamination and migration
Nature communications
October 30, 2017
Liu JA, Rao Y, Cheung MPL, Hui MN, Wu MH, Chan LK, Ng IO, Niu B, Cheah KSE, Sharma R,
et al
.
(
1:200
;
Santa Cruz
SC-271915
or
1:500
; BD Transduction Lab 612020),
mouse
anti-NEDD9 (
1:1000
;
Abcam
ab18056
), rabbit anti-GFP (
1:1000
;
Abcam
ab6556
), mouse anti-FAK (
1:500
; BD Transduction Lab 610088) and
Alexa Fluor 568 Phalloidin
(12)
The Prognostic Role of NEDD9 and P38 Protein Expression Levels in Urinary Bladder Transitional Cell Carcinoma
Journal of oncology
January 1, 2017
Harb OA, Haggag R, Ali MM, El Shorbagy S, Abdelbary AM, Abdelaziz LA, Salim RA, Abdel Wahab KM.
binding. Then the slides were incubated overnight with
mouse
monoclonal anti-NEDD9 antibody (NEDD9
clone
ab18056
, dilution
1 : 100
Abcam
, Cambridge, UK) and rabbit polyclonal anti-p38 protein antibody (
clone
ab197348
)
(13)
Tumor-suppressive role of HACE1 in hepatocellular carcinoma and its clinical significance
Oncology reports
December 1, 2016
Gao ZF, Wu YN, Bai ZT, Zhang L, Zhou Q, Li X.
three times, the specimens were incubated with rabbit monoclonal antibody against
human
HACE1 (
1:200
,
ab18056
;
Abcam
) at 4˚C overnight. Following washing with PBS for three times, the tissue sections were incubated
(14)
Genome-wide screen identifies novel machineries required for both ciliogenesis and cell cycle arrest upon serum starvation
Biochimica et biophysica acta
June 1, 2016
Kim JH, Ki SM, Joung JG, Scott E, Heynen-Genel S, Aza-Blanc P, Kwon CH, Kim J, Gleeson JG, Lee JE.
mouse
anti-MPS1 (cat. #
ab11108
,
Abcam
),
mouse
anti-PLK1 (cat. #
ab17057
,
Abcam
),
mouse
anti-HEF1
(cat. #
ab18056
,
Abcam
), mouse anti-beta-Actin (C4) (cat. #
sc-47778
,
Santa Cruz Biotechnology
), and
mouse
anti-Katanin
(15)
High expression of HEF1 predicts a poorer prognosis of hepatocellular carcinoma: A retrospective study
Molecular and clinical oncology
February 1, 2016
Li M, Yan S, Cai M, Lu J, Zhang M, Yang P, Luo R.
binding. Subsequently, the tissue sections were incubated with rabbit anti‑
human
anti ‑HEF1 (cat. no.
ab18056
; 10 µg/ml;
Abcam
, Burlingame, CA, USA) at 4˚C overnight. Replacement of the primary antibody with phosphate
(16)
Expression of NEDD9 in hepatocellular carcinoma and its clinical significance
Oncology reports
May 1, 2015
Lu P, Wang ZP, Dang Z, Zheng ZG, Li X, Zhou L, Ding R, Yue SQ, Dou KF.
washing, the sections were incubated with a monoclonal antibody against
human
NEDD9 (
1:1,000
;
Abcam
;
ab18056
) in PBS at 4˚C overnight. Biotinylated goat anti-mouse immunoglobulin G (IgG;
1:400
;
Abcam
;
ab128976
)
(17)
β-catenin inhibitor ICAT modulates the invasive motility of melanoma cells
Cancer research
April 1, 2014
Domingues MJ, Rambow F, Job B, Papon L, Liu W, Larue L, Bonaventure J.
(18)
The aryl hydrocarbon receptor regulates focal adhesion sites through a non-genomic FAK/Src pathway
Oncogene
April 4, 2013
Tomkiewicz C, Herry L, Bui LC, Métayer C, Bourdeloux M, Barouki R, Coumoul X.
METHODS Reagents and antibodies Antibodies to integrin beta 1 (
ab24693
and
ab52971
), paxillin (
ab32084
), HEF1(
ab18056
),
FAK
(
ab40794
) and phospho Tyr397
FAK
(
ab4803
) were from
Abcam
(Paris, France). Antibodies to E-cadherin
(19)
The overexpression of scaffolding protein NEDD9 promotes migration and invasion in cervical cancer via tyrosine phosphorylated FAK and SRC
PloS one
January 1, 2013
Sima N, Cheng X, Ye F, Ma D, Xie X, Lü W.
quantification quantitative analysis. Primary antibodies were specific for following proteins: NEDD9 (
ab18056
) from
Abcam
,
FAK
(
3285
), pFAK (
3283
), Src (
2109
), pSRC (
2101
), Phospho-Tyrosine (
9411
), Vimentin (
3932
)
(20)
The metastasis gene NEDD9 product acts through integrin β3 and Src to promote mesenchymal motility and inhibit amoeboid motility
Journal of cell science
April 1, 2012
Ahn J, Sanz-Moreno V, Marshall CJ.
Page
<<
<
1
2
>
>>
Reviews
Be the First to Write a Review!
Anti-HEF1/NEDD-9 antibody [2G9] from Abcam
Supplier Page
View Company Product Page
Pricing Info
Product Specs
Company Info
Citations
Reviews
Back To Top